BeStock  
Stocks › Biotechnology › MLYS

Mineralys Therapeutics MLYS

US equityMarket cap rank #2754Biotechnology
$23.30 −$0.33 (-1.40%)
Pre-market · Oct 6, 4:10 am ET · After hours $23.40 +0.43%
Open$23.98
Prev close$23.63
Day range$22.97 – $24.00
Volume1.08M
Market cap$2.06B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / book3.7x
CheapRich

Above its usual level · 74th percentile, 5-year average 2.1x

#3932 of 5315 stocks by PB (1 = cheapest)

Morningstar fair value estimate

Fair value$21.79
Price vs. fair value+6.9%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.74 – 2.08 74% (pricier than usual) #3932 of 5315 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$21.79
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on MLYS.

Leave a comment

Scroll to Top